lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) The age of the patient is 18 to 80 years; (2) Single lung lesion; (3) Complete excision after surgery; (4) Pathologically diagnosed as lung adenocarcinoma; (5) Subjects voluntarily joined the study, signed an informed consent form, had good compliance, and cooperated with follow-up.
Exclusion criteria
Exclusion criteria: (1) Pathologically confirmed non-primary lung adenocarcinoma; (2) A history of tumor or other malignant tumors at the same time; (3) Pregnant or lactating women; (4) Those suffering from hypertension who cannot fall within the normal range by antihypertensive drug treatment (systolic blood pressure>140 mmHg, diastolic blood pressure > 90 mmHg), suffering from myocardial ischemia or myocardial infarction or arrhythmia (including QT interval >= 440 ms) and grade I cardiac insufficiency; (5) There are multiple factors that affect surgery (such as moderate to severe lung function abnormalities, coagulation dysfunction, immune system diseases, etc.); (6) Long-term unhealed wounds or fractures; (7) Arterial/venous thrombotic events that occurred within 6 months before the consultation, such as cerebrovascular accidents (including temporary ischemic attacks), deep vein thrombosis and pulmonary embolism; (8) Those who have a history of psychotropic drug abuse and cannot be quit or have mental disorders; (9) Participated in other clinical trials within 3 months; (10) Have used anti-tumor therapy drugs (including Chinese medicine).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| prognosis;SEN, SPE, ACC, AUC of ROC, PPV, NPV, etc.; | — |
Countries
China
Contacts
Shanghai Pulmonary Hospital